In liver cancer research, apigenin can induce the expression of PTEN protein in human liver cancer cells, though inhibiting PI3K/AKT signaling and reducing the level of phosphorylated Bad protein, thereby achieving the effect of inducing liver cancer cell apoptosis (70); apigenin has also been proven to have therapeutic effects on cancer cells. Here, AKT1 is linked to cancer.